Dr. Farah Lim qualified from Imperial School of Medicine in 2004 with distinction in clinical practice and 1st class Honors in molecular biology. She trained in medical oncology at St Bartholomew's, completing her post-graduate training in 2012, followed by further specialist training in immune-oncology in solid tumors (breast/GU/Lung) which finished in 2017. She was appointed as a consultant in 2017, leading the lung immunotherapy/clinical trials unit. She has extensive experience in immune-oncology and has treated a wide variety of solid tumors with immunotherapy. Her areas of expertise include lung cancer.